United States · Venture startup

Who invested in bioProtonics

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$3.7Mraised across 2 rounds since 2024, from 2 sources

$2.7MVenture$1.0MRound
Latest round
Round, $1.0MApr 2026
Biggest round
$2.7MVenture · Dec 2024
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026
$2.7MVenture$1.0MRound
First round
Venture, $2.7M
Dec 2024
Biggest round
$2.7M
Venture · Dec 2024
Between rounds
16 months
from the last two

The rounds

  1. Apr 2026
    Round$1.0M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $1.0M sold, first sale Apr 2026

  2. Dec 2024
    Venture$2.7M1 new

    Source recordedSEC filing: $2.7M sold, first sale Dec 2024

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about bioProtonics

Who invested in bioProtonics?

bioProtonics's investors include National Science Foundation.

How much has bioProtonics raised?

bioProtonics has raised $3.7M across 2 rounds since 2024.

When did bioProtonics last raise?

bioProtonics's most recent round, $1.0M, was in Apr 2026.

What was bioProtonics's biggest round?

bioProtonics's largest round on record is $2.7M (Venture), in Dec 2024.

Who backed bioProtonics first?

bioProtonics's first round on record, in Dec 2024, was backed by National Science Foundation.

What stage is bioProtonics at?

bioProtonics's latest named round is a Venture, in Dec 2024.

Where is bioProtonics based?

bioProtonics is based in the United States.

Companies like bioProtonics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.